w 7 has been researched along with phenobarbital in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulyaeva, LF; Lyakhovich, VV; Mikhailova, ON; Pustylnyak, VO; Rice, RH; Zakharova, LY | 1 |
| Gulyaeva, LF; Lyakhovich, VV; Pustylnyak, VO | 1 |
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
3 other study(ies) available for w 7 and phenobarbital
| Article | Year |
|---|---|
In vivo effects of protein kinase and phosphatase inhibitors on CYP2B induction in rat liver.
Topics: Androstadienes; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cytochrome P-450 CYP2B1; Dioxanes; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Indoles; Liver; Male; Maleimides; Microsomes, Liver; Okadaic Acid; Phenobarbital; Phosphoinositide-3 Kinase Inhibitors; Phosphoprotein Phosphatases; Protein Kinase C; Rats; Rats, Wistar; RNA, Messenger; Sulfonamides; Wortmannin | 2005 |
CAR expression and inducibility of CYP2B genes in liver of rats treated with PB-like inducers.
Topics: Animals; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Constitutive Androstane Receptor; Cytochrome P-450 CYP2B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dioxanes; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Electrophoretic Mobility Shift Assay; Enzyme Activators; Enzyme Induction; Glyceraldehyde-3-Phosphate Dehydrogenases; Liver; Male; Nuclear Proteins; Phenobarbital; Phosphorylation; Protein Isoforms; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Transcription Factors | 2005 |
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |